02
23
2016
Biochemical Pharmacology granted Dr. Jun Wang, Medicilon’s VP of Biology, an “Outstanding Contribution in Reviewing” in recognition of the contribution made to the quality of the journal by Dr. Wang. Dr. Wang has served as Editorial Advisory Board since 2010.
02
22
2016
The author, Jean-François Tremblay, interviewed Dr. Chunlin Chen, CEO of Medicilon, about his view of the reform. Dr. Chen pointed out that the reform would have a positive impact and brought a healthy and long-lasting development to pharmaceutical industry in China. In addition, Dr. Chen mentioned that Chinese clients of Medicilon business accounted for less than 1% before, but now the Chinese clients accounted half of the Medicilon business.
02
03
2016
Dr. Chunlin Chen, CEO of Medicilon, wrote a report with the topic of “How to comply both US FDA and CFDA standard of preclinical studies?” and was posted on the first issue of Pharmaceutical Forum of Zhejiang Pharmaceutical Association.
02
03
2016
The Chemical & Engineering News (C&EN) recently published a special issue "How The Internet Changed Chemistry", which presented a very important point saying that "Internet plays a great role to save and reduce the development cost of pharmaceutical companies."
01
20
2016
Medicilon new instrument, IVIS Lumina Series Pre-clinical In Vivo Systems for our animal, has been in use. This new purchase is being improved and perfected Medicilon pre-clinical service.